**Core Concept**
The question is testing the use of sulfonamides in treating inflammatory bowel disease, specifically ulcerative colitis. Sulfonamides are a class of antimicrobials that work by inhibiting folic acid synthesis in bacteria.

**Why the Correct Answer is Right**
The correct answer is Sulfasalazine, which is a prodrug that releases sulfapyridine, a sulfonamide, in the colon. Sulfasalazine works by reducing inflammation and inhibiting the growth of bacteria in the colon, thereby treating ulcerative colitis. The mechanism of action involves the release of sulfapyridine, which is then metabolized to sulfapyridine-N4-acetyltransferase, which has anti-inflammatory properties.

**Why Each Wrong Option is Incorrect**
* **Option A:** Sulfadiazine is a sulfonamide used to treat bacterial infections, but it is not typically used to treat ulcerative colitis.
* **Option B:** Sulfamethoxazole is a sulfonamide used in combination with trimethoprim to treat bacterial infections, but it is not used to treat ulcerative colitis.
* **Option C:** Sulfadoxine is a sulfonamide used to treat malaria, but it is not used to treat ulcerative colitis.

**Clinical Pearl / High-Yield Fact**
Sulfasalazine is a classic example of a prodrug that releases an active moiety in a specific location, in this case, the colon. This property makes it useful for treating local inflammatory conditions.

**Correct Answer:** D. Sulfasalazine